Oral Semaglutide, A New Option in the Management of Type 2 Diabetes Mellitus: A Narrative Review
Crossref DOI link: https://doi.org/10.1007/s12325-020-01478-9
Published Online: 2020-09-04
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sofogianni, Areti
Tziomalos, Konstantinos http://orcid.org/0000-0002-3172-1594
Text and Data Mining valid from 2020-09-04
Version of Record valid from 2020-09-04
Article History
Received: 1 July 2020
First Online: 4 September 2020